KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amgen (AMGN) Return on Invested Capital (2016 - 2025)

Amgen has reported Return on Invested Capital over the past 17 years, most recently at 0.12% for Q4 2025.

  • Quarterly results put Return on Invested Capital at 0.12% for Q4 2025, up 3.0% from a year ago — trailing twelve months through Dec 2025 was 0.12% (up 3.0% YoY), and the annual figure for FY2025 was 0.12%, up 3.0%.
  • Return on Invested Capital for Q4 2025 was 0.12% at Amgen, up from 0.12% in the prior quarter.
  • Over the last five years, Return on Invested Capital for AMGN hit a ceiling of 0.21% in Q2 2022 and a floor of 0.08% in Q2 2024.
  • Median Return on Invested Capital over the past 5 years was 0.12% (2023), compared with a mean of 0.14%.
  • Biggest five-year swings in Return on Invested Capital: increased 6bps in 2022 and later dropped -10bps in 2023.
  • Amgen's Return on Invested Capital stood at 0.16% in 2021, then grew by 28bps to 0.2% in 2022, then plummeted by -52bps to 0.1% in 2023, then decreased by -1bps to 0.1% in 2024, then grew by 27bps to 0.12% in 2025.
  • The last three reported values for Return on Invested Capital were 0.12% (Q4 2025), 0.12% (Q3 2025), and 0.11% (Q2 2025) per Business Quant data.